Related Experiment Video

Updated: Jun 3, 2026

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening
05:54

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening

Published on: September 5, 2018

STAT3 signaling: anticancer strategies and challenges

Paul A Johnston1, Jennifer R Grandis

  • 1School of Pharmaceutical Sciences, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.

Molecular Interventions
|March 29, 2011
PubMed

Insights

Signal transducer and activator of transcription 3 (STAT3) is a key target in cancer therapy. Inhibiting STAT3 signaling offers promise for treating various human tumors, despite challenges in drug development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling

Background:

  • Signal transducer and activator of transcription 3 (STAT3) is implicated in the development, progression, and maintenance of numerous human cancers.
  • Activated STAT3 is linked to poor prognosis in many cancer types.
  • STAT3 regulates genes critical for cell differentiation, proliferation, apoptosis, angiogenesis, metastasis, and immune responses.

Purpose of the Study:

  • To review current approaches targeting STAT3 in cancer therapy.
  • To highlight the therapeutic potential and challenges of inhibiting the STAT3 signaling pathway.

Main Methods:

  • Literature review of STAT3 targeting strategies in oncology.
  • Analysis of the role of STAT3 in cancer pathogenesis and gene regulation.

Main Results:

  • STAT3 is a validated anti-cancer target in multiple tumor contexts.
  • Elevated STAT3 activation correlates with adverse patient outcomes.
  • Various strategies have been explored to therapeutically inhibit STAT3.

Conclusions:

  • Targeting STAT3 presents a promising avenue for anti-cancer drug development.
  • Challenges remain in developing effective and safe STAT3-inhibiting therapeutics.

More Related Videos

Three-Dimensional (3D) Tumor Spheroid Invasion Assay12:19

Three-Dimensional (3D) Tumor Spheroid Invasion Assay

Published on: May 1, 2015

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.